Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 4.0 | 5.0 |
Min SIP Amount | ₹500 | ₹100 |
Expense Ratio | 1.98 | 1.39 |
NAV | ₹26.26 | ₹1956.02 |
Fund Started | 26 Oct 2020 | 08 Dec 1994 |
Fund Size | ₹2111.62 Cr | ₹75784.48 Cr |
Exit Load | Exit load of 1% if redeemed within 3 months. | Exit load of 1% if redeemed within 1 year
|
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 4.40% | 11.37% |
3 Year | 22.83% | 25.56% |
5 Year | - | 30.17% |
1 Year
3 Year
5 Year
Equity | 97.61% | 87.46% |
Cash | 2.39% | 11.02% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
HDFC Bank Ltd. | 7.05% |
Reliance Industries Ltd. | 6.73% |
ICICI Bank Ltd. | 6.26% |
State Bank of India | 5.48% |
Indus Towers Ltd. | 4.52% |
Larsen & Toubro Ltd. | 4.42% |
ITC Ltd. | 4.31% |
Grasim Industries Ltd. | 4.02% |
Infosys Ltd. | 3.98% |
Bajaj Finance Ltd. | 3.65% |
Name | Assets |
---|---|
ICICI Bank Ltd. | 9.44% |
HDFC Bank Ltd. | 9.35% |
Axis Bank Ltd. | 8.48% |
Kotak Mahindra Bank Ltd. | 4.92% |
SBI Life Insurance Company Ltd. | 4.65% |
Maruti Suzuki India Ltd. | 4.13% |
Cipla Ltd. | 4.12% |
Bharti Airtel Ltd. | 2.89% |
HCL Technologies Ltd. | 2.64% |
Piramal Pharma Ltd. | 2.32% |
Name | Fatema Pacha | Dhruv Muchhal |
Start Date | 21 Dec 2020 | 14 Sep 2023 |
Name
Start Date
Description | The scheme seeks to generate long term capital appreciation by investing in a concentrated portfolio of equity & equity related instruments of maximum 30 companies across market capitalisation. | The scheme seeks to generate capital appreciation / income from a portfolio, predominantly invested in equity & equity related instruments. |
Launch Date | 26 Oct 2020 | 08 Dec 1994 |
Description
Launch Date